Education
About Us
Working with TipRanks
Follow Us
IntelGenx Technologies (IGXT)
OTHER OTC:IGXT
RESEARCH TOOLSreports
IGXT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.16 - $0.17
Previous CloseN/A
Volume37.23K
Average Volume (3M)0.00
Market Cap
$29.17M
Enterprise ValueN/A
Total Cash (Recent Filing)$772.00K
Total Debt (Recent Filing)$16.46M
Price to Earnings (P/E)―
Beta1.59
Next Earnings
Mar 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding174,658,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)-1.93
Price to Sales (P/S)0.00
P/FCF Ratio-6.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
IntelGenx Technologies News
PremiumCompany Announcements
IntelGenx Restructures and Leadership Overhaul Approved
PremiumCompany Announcements
IntelGenx Shows Promise in Alzheimer’s StudyPremiumCompany Announcements
IntelGenx Initiates Strategic Sale Process
PremiumCompany Announcements
IntelGenx Begins Strategic Restructuring Efforts
PremiumCompany Announcements
IntelGenx Initiates Strategic Restructuring ProcessOptions Prices
Currently, No data available
---
Ownership Overview
5.42%
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
IGXT FAQ
What was IntelGenx Technologies’s price range in the past 12 months?
IntelGenx Technologies lowest stock price was $0.16 and its highest was $0.17 in the past 12 months.
What is IntelGenx Technologies’s market cap?
IntelGenx Technologies’s market cap is $29.17M.
When is IntelGenx Technologies’s upcoming earnings report date?
IntelGenx Technologies’s upcoming earnings report date is Mar 20, 2025 which is 95 days ago.
How were IntelGenx Technologies’s earnings last quarter?
Currently, no data Available
Is IntelGenx Technologies overvalued?
According to Wall Street analysts IntelGenx Technologies’s price is currently Overvalued.
Does IntelGenx Technologies pay dividends?
IntelGenx Technologies does not currently pay dividends.
What is IntelGenx Technologies’s EPS estimate?
IntelGenx Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IntelGenx Technologies have?
IntelGenx Technologies has 174,658,100 shares outstanding.
What happened to IntelGenx Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of IntelGenx Technologies?
Currently, no hedge funds are holding shares in IGXT
Company Description
IntelGenx Technologies
IntelGenx Technologies Corp. is a leading pharmaceutical company engaged in the development and manufacturing of innovative oral thin film products. The company focuses on the healthcare sector, specializing in novel drug delivery technologies that enhance the efficacy and safety of pharmaceutical products. IntelGenx's core services include the development of proprietary oral thin film formulations and the advancement of a robust product pipeline targeting a range of therapeutic areas.